A great relief to both of you then that all our biotech investor and development partner meetings were conducted not in OZ but in the US by our newly added board members, who joined us in March this year.
This won't act like an Australian biotech company, positive results will validate the entire ocular, possibly the entire pipeline. US based investors will progressively buy into the entity on funding news.
all IMO
PYC Price at posting:
13.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)